I67.5
Moyamoya disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Moyamoya disease is a rare, progressive neurological disorder characterized by the narrowing or blockage of arteries at the base of the brain. This impairs blood flow to essential areas of the brain, potentially leading to strokes, transient ischemic attacks (TIAs), and neurological deficits. The term 'moyamoya' means 'puff of smoke' in Japanese, describing the appearance of tangled blood vessels visible on imaging studies. While it can affect individuals of any age, it is most commonly diagnosed in children and young adults. Recognizing the signs and understanding the nature of this disease is vital for prompt diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic predisposition, especially in Asian populations Autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus Down syndrome and neurofibromatosis type 1 History of trauma or radiation exposure Unknown, in many cases, with no identifiable cause
Key Symptoms: Transient ischemic attacks (TIAs) with symptoms like weakness, numbness, or paralysis on one side of the body Sudden weakness or numbness in limbs, often on one side Speech difficulties or confusion Loss of coordination and balance, leading to falls Seizures in some cases Headaches that may intensify during activity or stress In children, delays in physical development or learning difficulties
Diagnostic & Treatment
Diagnosis Path: Magnetic Resonance Angiography (MRA): Non-invasive imaging to assess blood flow and vessel structure Computed Tomography Angiography (CTA): Provides detailed images of cerebral arteries Conventional Cerebral Angiography: Considered the gold standard for diagnosis, offering detailed visualization of arterial narrowing and collateral vessel formation
Treatment Protocols: Medications such as antiplatelet agents (e.g., aspirin) to reduce clot formation Surgical procedures to enhance cerebral blood flow, including revascularization surgeries like direct/bypass or indirect methods Management of symptoms and prevention of stroke through lifestyle modifications and controlling blood pressure Regular monitoring with imaging studies to assess disease progression
Clinical Advice & FAQs
Billing Guidance
Is I67.5 a billable ICD-10 code?
Yes, I67.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I67.5?
Clinical documentation must specify the nature of Moyamoya disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference